Cargando…

Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells

Arginine is a critical amino acid in specific cancer types including hepatocellular carcinoma (HCC) and melanoma. Novel molecular mechanisms and therapeutic targets in arginine metabolism-mediated cancer formation await further identification. Our laboratory has previously demonstrated that arginine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Yu-Hsuan, Huang, Hau-Lun, Chen, Wei-Ching, Yen, Meng-Chi, Cho, Chien-Yu, Weng, Tzu-Yang, Wang, Chih-Yang, Chen, Yi-Ling, Chen, Li-Tzong, Lai, Ming-Derg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355748/ https://www.ncbi.nlm.nih.gov/pubmed/28035420 http://dx.doi.org/10.3892/or.2016.5334

Ejemplares similares

Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines
por: Shan, Yan-Shen, et al.
Publicado: (2015)

Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
por: Syed, N, et al.
Publicado: (2013)

Refeeding syndrome in a young woman with argininosuccinate lyase deficiency()
por: Stuy, M., et al.
Publicado: (2015)

Increased expression of argininosuccinate synthetase protein predicts poor prognosis in human gastric cancer
por: SHAN, YAN-SHEN, et al.
Publicado: (2015)

Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer
por: Chen, Wei-Ching, et al.
Publicado: (2016)

Identification of mutations in Malaysian patients with argininosuccinate lyase (ASL) deficiency
por: Ali, Ernie Zuraida, et al.
Publicado: (2019)

Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer
por: Karvelsson, Sigurdur Trausti, et al.
Publicado: (2021)

Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer
por: Shan, Yan-Shen, et al.
Publicado: (2017)

Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells
por: Zheng, Liang, et al.
Publicado: (2013)

Functional Characterization of Argininosuccinate Lyase Gene Variants by Mini-Gene Splicing Assay
por: Wang, Yanyun, et al.
Publicado: (2019)

Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases
por: Weng, Tzu-Yang, et al.
Publicado: (2016)

Down-regulation of argininosuccinate lyase induces hepatoma cell apoptosis through activating Bax signaling pathway
por: Gong, Rui, et al.
Publicado: (2018)

Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin
por: Chen, Wei-Ching, et al.
Publicado: (2016)

Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer
por: Chen, Wei-Ching, et al.
Publicado: (2015)

Homoharringtonine induced immune alteration for an Efficient Anti-tumor Response in Mouse Models of Non-small Cell Lung Adenocarcinoma Expressing Kras Mutation
por: Weng, Tzu-Yang, et al.
Publicado: (2018)

Argininosuccinate lyase deficiency causes blood-brain barrier disruption via nitric oxide–mediated dysregulation of claudin expression
por: Kho, Jordan, et al.
Publicado: (2023)

MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer
por: Cho, Chien-Yu, et al.
Publicado: (2016)

Whole-Exome Sequencing Identified a Novel Compound Heterozygous Genotype in ASL in a Chinese Han Patient with Argininosuccinate Lyase Deficiency
por: Zhao, Mei, et al.
Publicado: (2019)

The gene expression and bioinformatic analysis of choline trimethylamine-lyase (CutC) and its activating enzyme (CutD) for gut microbes and comparison with their TMA production levels
por: Ramireddy, Latha, et al.
Publicado: (2021)

Skin Delivery of Clec4a Small Hairpin RNA Elicited an Effective Antitumor Response by Enhancing CD8(+) Immunity In Vivo
por: Weng, Tzu-Yang, et al.
Publicado: (2017)

Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53
por: Miyamoto, Takafumi, et al.
Publicado: (2017)

HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma
por: Liang, Peir-In, et al.
Publicado: (2012)

Mucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling
por: Hsu, Hui-Ping, et al.
Publicado: (2017)

Novel mutations underlying argininosuccinic aciduria in Saudi Arabia
por: Imtiaz, Faiqa, et al.
Publicado: (2010)

Expanding the phenotype in argininosuccinic aciduria: need for new therapies
por: Baruteau, Julien, et al.
Publicado: (2017)

Epithelial argininosuccinate synthetase is dispensable for intestinal regeneration and tumorigenesis
por: van der Meer, Jonathan H. M., et al.
Publicado: (2021)

Suppression of mucin 2 promotes interleukin-6 secretion and tumor growth in an orthotopic immune-competent colon cancer animal model
por: SHAN, YAN-SHEN, et al.
Publicado: (2014)

A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors
por: Ding, Qiang, et al.
Publicado: (2023)

Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor
por: Zou, Zizheng, et al.
Publicado: (2021)

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
por: Savaraj, Niramol, et al.
Publicado: (2007)

A transgenic approach to study argininosuccinate synthetase gene expression
por: Shiue, Shih-Chang, et al.
Publicado: (2014)

Argininosuccinate synthase 1, arginine deprivation therapy and cancer management
por: Sun, Naihui, et al.
Publicado: (2022)

PODXL2 maintains cellular stemness and promotes breast cancer development through the Rac1/Akt pathway
por: Lin, Yi-Yi, et al.
Publicado: (2020)

Citrullinemia type I in Chinese children: Identification of two novel argininosuccinate synthetase gene mutations
por: Xiong, Mei, et al.
Publicado: (2022)

Voltage-gated calcium channels: Novel targets for cancer therapy
por: Phan, Nam Nhut, et al.
Publicado: (2017)

Repurposing nitric oxide donating drugs in cancer therapy through immune modulation
por: Li, Chung-Yen, et al.
Publicado: (2023)

Multifaceted interactions and regulation between antizyme and its interacting proteins cyclin D1, ornithine decarboxylase and antizyme inhibitor
por: Liu, Yen-Chin, et al.
Publicado: (2015)

Expression profile and down-regulation of argininosuccinate synthetase in hepatocellular carcinoma in a transgenic mouse model
por: Shiue, Shih-Chang, et al.
Publicado: (2015)

Leishmania donovani Argininosuccinate Synthase Is an Active Enzyme Associated with Parasite Pathogenesis
por: Lakhal-Naouar, Ines, et al.
Publicado: (2012)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qlfetnev05t5qh24gg40rvu817